抗ＣＡＤＭ１抗体またはその抗原結合断片
【課題】ＳＡＲＳ－ＣｏＶ－２の処置に使用できる可能性がある、新たな抗体を提供する。【解決手段】抗ＣＡＤＭ１抗体またはその抗原結合断片であって、前記抗体は、下記（Ｃａ）および（Ｃｂ）からなる群から選択される。（Ｃａ）それぞれ、特定の配列を有する重鎖ＣＤＲ１、重鎖ＣＤＲ２および重鎖ＣＤＲ３と、それぞれ、特定の配列を有する軽鎖ＣＤＲ１、軽鎖ＣＤＲ２および軽鎖ＣＤＲ３のアミノ酸配列を含む抗体；（Ｃｂ）前記重鎖ＣＤＲ１、前記重鎖ＣＤＲ２、前記重鎖ＣＤＲ３、前記軽鎖ＣＤＲ１、前記軽鎖ＣＤＲ２、および／または前記軽鎖ＣＤＲ３に、１数個の置換、挿入、付加もしくは欠失を含む（ａ）抗体の変異体。【選択図】図７.
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 26. März Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Japanisch |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-03-26, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 |
|---|
| Patentnummer: |
JP2024041027 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA003324923 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA003324923 | ||
| 003 | DE-627 | ||
| 005 | 20240426160030.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240415s2024 xx |||||o 00| ||jpn c | ||
| 035 | |a (DE-627)EPA003324923 | ||
| 035 | |a (EPA)JP2024041027 | ||
| 035 | |a (EPA)86382686 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a jpn | ||
| 245 | 1 | 0 | |a 抗ＣＡＤＭ１抗体またはその抗原結合断片 |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-03-26, Last update posted on www.tib.eu: 2024-04-23, Last updated: 2024-04-26 | ||
| 520 | |a 【課題】ＳＡＲＳ－ＣｏＶ－２の処置に使用できる可能性がある、新たな抗体を提供する。【解決手段】抗ＣＡＤＭ１抗体またはその抗原結合断片であって、前記抗体は、下記（Ｃａ）および（Ｃｂ）からなる群から選択される。（Ｃａ）それぞれ、特定の配列を有する重鎖ＣＤＲ１、重鎖ＣＤＲ２および重鎖ＣＤＲ３と、それぞれ、特定の配列を有する軽鎖ＣＤＲ１、軽鎖ＣＤＲ２および軽鎖ＣＤＲ３のアミノ酸配列を含む抗体；（Ｃｂ）前記重鎖ＣＤＲ１、前記重鎖ＣＤＲ２、前記重鎖ＣＤＲ３、前記軽鎖ＣＤＲ１、前記軽鎖ＣＤＲ２、および／または前記軽鎖ＣＤＲ３に、１数個の置換、挿入、付加もしくは欠失を含む（ａ）抗体の変異体。【選択図】図７ | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a tec | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a G01N: Investigating or analysing materials by determining their chemical or physical properties (measuring or testing processes other than immunoassay, involving enzymes or microorganisms c12m, c12q) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000) | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 26. März |
| 773 | 1 | 8 | |g year:2024 |g day:26 |g month:03 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/86382686/publication/JP2024041027A1?q=JP2024041027 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 26 |c 03 | ||